Pharmaceutical Equity Act of 1996

Summary

Pharmaceutical Equity Act of 1996 - Extends for a two-year period the term of any patent in force on September 24, 1984, and on this Act's effective date, that claims a drug product or a method of using or manufacturing it from the product's expiration date if: (1) an exemption became effective for the drug product before September 24, 1984; (2) the regulatory review period for such product exceeded 120 months or 60 months, as appropriate. Provides that during such extensions, the rights in the extended patents shall be the same as those that existed before their expirations, thereby guarding against patent infringements during the extensions. Requires: (1) the patentee to notify the Commissioner of Patents and Trademarks of such patent extended number; and (2) the Commissioner to confirm the patent extension by placing a notice thereof in the official file of the patent and to publish an appropriate notice in the Official Gazette of the Patent and Trademark Office.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 28 September 1996

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 28 September 1996

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 28 September 1996

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.